Tumor fluorescence and oxygenation monitoring during photodynamic therapy with chlorin e6 photosensitizer

Photodiagnosis Photodyn Ther. 2024 Feb:45:103969. doi: 10.1016/j.pdpdt.2024.103969. Epub 2024 Jan 10.

Abstract

Background: The study is aimed at developing a method for monitoring photodynamic therapy (PDT) of a tumor using chlorin-type photosensitizers (PSs). Lack of monitoring of chlorin e6 (Cе6) photobleaching, hemoglobin oxygenation and blood flow during light exposure can limit the PDT effectiveness.

Materials and methods: Phototheranostics includes spectral-fluorescence diagnostics of Ce6 distribution in the NIR range and PDT with simultaneous assessment of hemoglobin oxygenation and tumor blood flow. Fluorescence diagnostics and PDT were performed using the single laser λexc=660 ± 5 nm.

Results: Combined spectroscopic PDT monitoring method allowed simultaneous estimation of Ce6 photobleaching, hemoglobin oxygenation and tumor vascular thrombosis during PDT without interrupting the therapeutic light exposure.

Conclusion: The developed method of tumor phototheranostics using chlorin-type PSs may make it possible to personalize the duration of therapeutic light exposure during PDT.

Keywords: Chlorin e6; Fluorescence diagnostics; Hemoglobin oxygenation; Photobleaching; Photodynamic therapy; Phototheranostics; Vascular thrombosis.

MeSH terms

  • Chlorophyllides*
  • Fluorescence
  • Hemoglobins
  • Humans
  • Neoplasms*
  • Photochemotherapy* / methods
  • Photosensitizing Agents / therapeutic use

Substances

  • Photosensitizing Agents
  • phytochlorin
  • Hemoglobins
  • Chlorophyllides